These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 32998431)
1. Indoxyl Sulfate-Mediated Metabolic Alteration of Transcriptome Signatures in Monocytes of Patients with End-Stage Renal Disease (ESRD). Kim HY; Lee SJ; Hwang Y; Lee GH; Yoon CE; Kim HC; Yoo TH; Lee WW Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32998431 [TBL] [Abstract][Full Text] [Related]
2. Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD). Kim HY; Yoo TH; Hwang Y; Lee GH; Kim B; Jang J; Yu HT; Kim MC; Cho JY; Lee CJ; Kim HC; Park S; Lee WW Sci Rep; 2017 Jun; 7(1):3057. PubMed ID: 28596556 [TBL] [Abstract][Full Text] [Related]
3. Uremic toxin indoxyl sulfate induces trained immunity via the AhR-dependent arachidonic acid pathway in end-stage renal disease (ESRD). Kim HY; Kang YJ; Kim DH; Jang J; Lee SJ; Kim G; Koh HB; Ko YE; Shin HM; Lee H; Yoo TH; Lee WW Elife; 2024 Jul; 12():. PubMed ID: 38980302 [TBL] [Abstract][Full Text] [Related]
4. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study. Crespo-Salgado J; Vehaskari VM; Stewart T; Ferris M; Zhang Q; Wang G; Blanchard EE; Taylor CM; Kallash M; Greenbaum LA; Aviles DH Microbiome; 2016 Sep; 4(1):50. PubMed ID: 27640125 [TBL] [Abstract][Full Text] [Related]
5. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure. Lin CJ; Wu V; Wu PC; Wu CJ PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073 [TBL] [Abstract][Full Text] [Related]
6. Alteration of human blood cell transcriptome in uremia. Scherer A; Günther OP; Balshaw RF; Hollander Z; Wilson-McManus J; Ng R; McMaster WR; McManus BM; Keown PA BMC Med Genomics; 2013 Jun; 6():23. PubMed ID: 23809614 [TBL] [Abstract][Full Text] [Related]
7. [The uremic toxin, indoxyl sulfate, signifies cardio-renal risk and intestinal-renal relationship]. Kiss I Orv Hetil; 2011 Oct; 152(43):1724-30. PubMed ID: 21983398 [TBL] [Abstract][Full Text] [Related]
8. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease. Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. Pandolfi A; Di Pietro N; Sirolli V; Giardinelli A; Di Silvestre S; Amoroso L; Di Tomo P; Capani F; Consoli A; Bonomini M J Cell Physiol; 2007 Dec; 213(3):699-709. PubMed ID: 17516566 [TBL] [Abstract][Full Text] [Related]
12. Comment on Indoxyl Sulfate-Review of Toxicity and Therapeutic Strategies. Toxins 2016, 8, 358. Barreto FC; Barreto DV; Stinghen AEM; Massy ZA Toxins (Basel); 2017 Apr; 9(4):. PubMed ID: 28420181 [TBL] [Abstract][Full Text] [Related]
13. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001 [TBL] [Abstract][Full Text] [Related]
14. [Research progress of the uremic toxin indoxyl sulfate in cardiovascular complication of end-stage renal diseases]. Guo CC; Xia WW; Zhang AH Sheng Li Xue Bao; 2018 Dec; 70(6):657-662. PubMed ID: 30560276 [TBL] [Abstract][Full Text] [Related]
15. Effect of uremic toxin-indoxyl sulfate on the skeletal system. Liu WC; Wu CC; Lim PS; Chien SW; Hou YC; Zheng CM; Shyu JF; Lin YF; Lu KC Clin Chim Acta; 2018 Sep; 484():197-206. PubMed ID: 29864403 [TBL] [Abstract][Full Text] [Related]
16. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia. Lim CF; Bernard BF; de Jong M; Docter R; Krenning EP; Hennemann G J Clin Endocrinol Metab; 1993 Feb; 76(2):318-24. PubMed ID: 8432774 [TBL] [Abstract][Full Text] [Related]
18. Indoxyl sulfate suppresses endothelial progenitor cell-mediated neovascularization. Hung SC; Kuo KL; Huang HL; Lin CC; Tsai TH; Wang CH; Chen JW; Lin SJ; Huang PH; Tarng DC Kidney Int; 2016 Mar; 89(3):574-85. PubMed ID: 26880454 [TBL] [Abstract][Full Text] [Related]
19. Indoxyl sulfate-induced TNF-α is regulated by crosstalk between the aryl hydrocarbon receptor, NF-κB, and SOCS2 in human macrophages. Kim HY; Yoo TH; Cho JY; Kim HC; Lee WW FASEB J; 2019 Oct; 33(10):10844-10858. PubMed ID: 31284759 [TBL] [Abstract][Full Text] [Related]
20. Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells. Motojima M; Hosokawa A; Yamato H; Muraki T; Yoshioka T Kidney Int; 2003 May; 63(5):1671-80. PubMed ID: 12675842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]